| AstraZeneca AG - Zoladex LA SafeSystem, Fertigspritze mit Implantat |
| 53371 | | 02 | | Zoladex LA SafeSystem | | Fertigspritze mit Implantat | | L02AE03 | | Goserelin | | 12.07.2004 | | |
|
| Composition |
| goserelinum 10.8 mg ut goserelini acetas, poly(lactidum-co-glycolidum) pro praeparatione. |
| Packungsbestandteile |
| Fertigspritze mit Implantat | | | | | | | | Active Agent | Dose |
|---|
| Gosereline | 10.8 mg |
| | BAG: Active Agent | Dose |
|---|
| Gosereline | 10.8 mg |
| | | | Inactive agents |
|---|
| Poly(Lactidum-Co-Glycolidum) |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 027 | syringe(s) | 373.44 | 422.55 | A | SL | No |
|
